AstraZeneca Asks Fed. Circ. To Reopen Nexium Patent Suit

By Sindhu Sundar (September 5, 2013, 8:06 PM EDT) -- AstraZeneca AB on Tuesday asked the Federal Circuit to revive its suit against Hanmi Pharmaceutical Co. Ltd., arguing a lower court had wrongly found that the South Korean drugmaker's copycat version of the acid reflux medication Nexium does not violate AstraZeneca's patents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!